
Sign up to save your podcasts
Or


We are beginning a new series today. John and Adam will discuss a couple of articles we found interesting. Please let us know your thoughts. This week:
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
Tiotropium Initiation and Dementia Risk in Chronic Obstructive Pulmonary Disease
By Sensible Medicine Authors and Editors4.9
135135 ratings
We are beginning a new series today. John and Adam will discuss a couple of articles we found interesting. Please let us know your thoughts. This week:
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
Tiotropium Initiation and Dementia Risk in Chronic Obstructive Pulmonary Disease

1,888 Listeners

4,264 Listeners

2,455 Listeners

885 Listeners

2,881 Listeners

295 Listeners

2,440 Listeners

137 Listeners

193 Listeners

564 Listeners

424 Listeners

373 Listeners

8,697 Listeners

66 Listeners

1,082 Listeners